Ustekinumab for the treatment of adults with moderate to severe psoriasis

Technology appraisal guidance
Reference number: TA180
Published: 23 September 2009
Last updated: 03 March 2017

Psoriasis - ustekinumab: Expert written personal statements - Anstey

Clinical expert, nominated by The British Association of Dermatologists (Professor Alex Anstey – Consultant Dermatologist)

Psoriasis - ustekinumab: Expert written personal statements - Anstey

Psoriasis - ustekinumab: Expert written personal statements - Anstey
20 May 2009
(20.06 Kb 5 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 30 March 2010